Innovative Products & Tools for Cancer Research

Empower Your Cancer Research


Our company helps predict cancer with novel discovery tools, characterize cancer with proven platforms, and drive cancer therapeutics through approval and production. As a company with a robust cancer research division, we know what works. Researchers are stronger in the fight with an oncology partner in their corner.

Visit us at AACR in Washington DC, April 1–5, 2017, booth 931.
Click here for more information and registration.
 

Predict cancer with novel discovery tools and biomarkers

Predict cancer with novel discovery tools and biomarkers.

Characterize cancer with a proven platform for cell line engineering and predictive cell models

Characterize cancer with a proven platform for cell line engineering and predictive cell models.

Drive cancer therapeutics through approval and production

Drive cancer therapeutics through approval and production.

 Predict Cancer

Early cancer detection translates directly into options for patients and better outcomes for many types of cancer. Researchers focus more than ever on finding reliable early cancer biomarkers. The development of CRISPR libraries and off-the-shelf assay kits has reduced time and cost outlays of this process and increased the likelihood of clinical success in drug approval.

 Characterize Cancer

Once a target is identified and biomarkers are validated, a biologically relevant in vitro model is constructed for lead discovery. At this stage, researchers look to cut costs and improve speed to eliminate leads quickly and evaluate the efficacy and safety of those that remain. Results from in vitro screenings must then be transferred to the clinical setting. Service providers must be technologically adept and able to deliver on precise client needs to meet high clinical standards.

 Drive Cancer

Over 50% of late-stage oncology drugs are large molecules and drug developers/manufacturers require strong partnerships to get their products through the clinic and ultimately commercially approved. Selecting a service provider who can provide speed to clinic without quality compromise and has a firm understanding of regulatory guidelines can be difficult to find. As a drug heads toward commercial approval, it’s important to rely on partners with extensive understanding of process and analytical development, manufacturability, quality and regulatory expectations. Our end-to-end solutions cover all aspects of biodevelopment/bioproduction from early phase preclinical activities through to single-use manufacturing at commercial scale.